|
JPS5742852A
(en)
*
|
1980-08-27 |
1982-03-10 |
Seikagaku Kogyo Co Ltd |
Erythrocyte sensitized with antibody of polysaccharide of hemolytic streptococcus
|
|
US4867973A
(en)
|
1984-08-31 |
1989-09-19 |
Cytogen Corporation |
Antibody-therapeutic agent conjugates
|
|
US5156840A
(en)
|
1982-03-09 |
1992-10-20 |
Cytogen Corporation |
Amine-containing porphyrin derivatives
|
|
US4950738A
(en)
|
1984-09-13 |
1990-08-21 |
Cytogen Corporation |
Amine derivatives of anthracycline antibiotics
|
|
US5140104A
(en)
|
1982-03-09 |
1992-08-18 |
Cytogen Corporation |
Amine derivatives of folic acid analogs
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
US5162512A
(en)
|
1982-03-09 |
1992-11-10 |
Cytogen Corporation |
Amine derivatives of anthracycline antibodies
|
|
CA1203164A
(en)
|
1982-03-09 |
1986-04-15 |
Thomas J. Mckearn |
Antibody conjugates
|
|
US4741900A
(en)
|
1982-11-16 |
1988-05-03 |
Cytogen Corporation |
Antibody-metal ion complexes
|
|
SU1163864A1
(ru)
*
|
1983-01-19 |
1985-06-30 |
Ордена Ленина Институт Химической Физики Ан Ссср |
Способ определени антиэритроцитарных антител
|
|
EP0119650A3
(en)
|
1983-03-21 |
1987-09-30 |
THE PROCTER & GAMBLE COMPANY |
Galactosyl-insulin conjugates useful in treating diabetics
|
|
JPS59173762A
(ja)
*
|
1983-03-22 |
1984-10-01 |
Green Cross Corp:The |
逆受身抗体赤血球凝集反応用試薬
|
|
CA1260827A
(en)
|
1984-08-31 |
1989-09-26 |
Richard C. Siegel |
Antibody-metal ion complexes
|
|
WO1986001720A1
(en)
|
1984-09-13 |
1986-03-27 |
Cytogen Corporation |
Antibody therapeutic agent conjugates
|
|
CA1330378C
(en)
|
1986-05-08 |
1994-06-21 |
Daniel J. Coughlin |
Amine derivatives of folic acid analogs
|
|
US5086002A
(en)
*
|
1987-09-07 |
1992-02-04 |
Agen Biomedical, Ltd. |
Erythrocyte agglutination assay
|
|
US20030022826A1
(en)
|
1987-09-08 |
2003-01-30 |
Duke University |
Use of synthetic peptides to induce tolerance to pathogenic T and B cell epitopes of autoantigens or infectious agents
|
|
US4859449A
(en)
|
1987-09-14 |
1989-08-22 |
Center For Molecular Medicine And Immunology |
Modified antibodies for enhanced hepatocyte clearance
|
|
NZ226202A
(en)
*
|
1987-09-17 |
1992-01-29 |
Agen Ltd |
Erythrocyte agglutination assay
|
|
US5227293A
(en)
|
1989-08-29 |
1993-07-13 |
The General Hospital Corporation |
Fusion proteins, their preparation and use
|
|
US5358857A
(en)
|
1989-08-29 |
1994-10-25 |
The General Hospital Corp. |
Method of preparing fusion proteins
|
|
US5227165A
(en)
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
|
WO1991008770A1
(en)
|
1989-12-11 |
1991-06-27 |
Immunomedics, Inc. |
Method for antibody targeting of diagnostic or therapeutic agents
|
|
JPH0436185A
(ja)
|
1990-03-28 |
1992-02-06 |
Kyowa Hakko Kogyo Co Ltd |
融合抗原ポリペプチド
|
|
AU8869291A
(en)
|
1990-10-04 |
1992-04-28 |
University Of Virginia Alumni Patents Foundation, The |
Primate erythrocyte bound monoclonal antibody heteropolymers
|
|
KR950014915B1
(ko)
|
1991-06-19 |
1995-12-18 |
주식회사녹십자 |
탈시알로당단백-포함화합물
|
|
GB9219562D0
(en)
*
|
1992-03-11 |
1992-10-28 |
Prendergast Kennet F |
Anti-viral peptides
|
|
DE69329145D1
(de)
|
1992-03-11 |
2000-09-07 |
Kenneth Francis Prendergast |
Anti-virale Fusionspeptide
|
|
US6217869B1
(en)
|
1992-06-09 |
2001-04-17 |
Neorx Corporation |
Pretargeting methods and compounds
|
|
GB9223084D0
(en)
|
1992-11-04 |
1992-12-16 |
Imp Cancer Res Tech |
Compounds to target cells
|
|
EP0602290B1
(en)
|
1992-12-04 |
1999-08-25 |
ConjuChem, Inc. |
Antibody-conjugated Hepatitis B surface antigen and use thereof
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
EP0716703A1
(en)
*
|
1993-09-03 |
1996-06-19 |
PRENDERGAST, Kenneth, Francis |
Glycophorin binding protein (gbp130) fusion compositions
|
|
US6153203A
(en)
|
1993-10-08 |
2000-11-28 |
Duotol Ab |
Immunological tolerance-inducing agent
|
|
US5681571A
(en)
|
1993-10-08 |
1997-10-28 |
Duotol Ab |
Immunological tolerance-inducing agent
|
|
AU696964B2
(en)
*
|
1994-02-28 |
1998-09-24 |
University Of Virginia Patent Foundation |
Antigen-based heteropolymers and method for treating autoimmune diseases using the same
|
|
US5698679A
(en)
|
1994-09-19 |
1997-12-16 |
National Jewish Center For Immunology And Respiratory Medicine |
Product and process for targeting an immune response
|
|
US5997861A
(en)
|
1994-10-31 |
1999-12-07 |
Burstein Laboratories, Inc. |
Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin
|
|
US5718915A
(en)
|
1994-10-31 |
1998-02-17 |
Burstein Laboratories, Inc. |
Antiviral liposome having coupled target-binding moiety and hydrolytic enzyme
|
|
US5886143A
(en)
|
1994-12-07 |
1999-03-23 |
Neorx Corporation |
Hepatic-directed compounds and reagents for preparation thereof
|
|
US20040258688A1
(en)
|
1995-01-31 |
2004-12-23 |
Daniel Hawiger |
Enhanced antigen delivery and modulation of the immune response therefrom
|
|
US20020187131A1
(en)
|
1995-01-31 |
2002-12-12 |
Daniel Hawiger |
Enhanced antigen delivery and modulation of the immune response therefrom
|
|
JPH10513350A
(ja)
|
1995-01-31 |
1998-12-22 |
ザ ロックフェラー ユニヴァーシティ |
ＤＥＣ（樹状細胞及び上皮細胞、２０５ ｋＤａ）の同定、Ｃ型レクチンドメインを有するレセプター、ＤＥＣをコードする核酸、及びこれらの使用
|
|
ATE458499T1
(de)
|
1995-06-07 |
2010-03-15 |
Immunomedics Inc |
Verbesserte abgabe von diagnostischen und therapeutischen stoffen an einem zielort
|
|
US6512103B1
(en)
|
1995-12-08 |
2003-01-28 |
Schering Corporation |
Mammalian chemokine reagents
|
|
US6060054A
(en)
|
1996-04-10 |
2000-05-09 |
National Jewish Medical And Research Center |
Product for T lymphocyte immunosuppression
|
|
US6124128A
(en)
*
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
|
EP0930874A2
(en)
|
1996-10-09 |
1999-07-28 |
Takeda Chemical Industries, Ltd. |
A method for producing a microparticle
|
|
US5994104A
(en)
|
1996-11-08 |
1999-11-30 |
Royal Free Hospital School Of Medicine |
Interleukin-12 fusion protein
|
|
US20090280132A1
(en)
|
1997-01-07 |
2009-11-12 |
Habib Zaghouani |
Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease
|
|
US20030103967A1
(en)
|
1997-01-07 |
2003-06-05 |
Habib Zaghouani |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
US20020081298A1
(en)
|
1997-01-07 |
2002-06-27 |
Habib Zaghouani |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
US6737057B1
(en)
|
1997-01-07 |
2004-05-18 |
The University Of Tennessee Research Corporation |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
US20070218053A1
(en)
|
1997-01-07 |
2007-09-20 |
Habib Zaghouani |
Coupling of peripheral tolerance to endogenous il-10 promotes effective modulation of t cells and ameliorates autoimmune disease
|
|
US5948639A
(en)
|
1997-04-10 |
1999-09-07 |
Millennium Pharmaceuticals, Inc. |
TGF-β pathway genes
|
|
NZ500284A
(en)
|
1997-04-18 |
2001-09-28 |
Biogen Inc |
Type II TGF-beta receptor fusion proteins
|
|
CU22737A1
(es)
|
1997-04-28 |
2002-02-28 |
Ct Ingenieria Genetica Biotech |
Proteínas de fusión recombinantes basadas en adhesinas bacterianas para el desarrollo de ensayos diagnóstico
|
|
US6120770A
(en)
*
|
1997-09-12 |
2000-09-19 |
University Of Notre Dame Du Lac |
Plasmodium proteins useful for preparing vaccine compositions
|
|
US6953675B2
(en)
|
1997-11-06 |
2005-10-11 |
Immunomedics, Inc. |
Landscaped antibodies and antibody fragments for clinical use
|
|
JP2002509158A
(ja)
|
1998-01-15 |
2002-03-26 |
センター・フォー・モレキュラー・メディシン・アンド・イムノロジー |
アーム付きリガンドの送達向上のための抗体と受容体ターゲティング部分
|
|
US6703488B1
(en)
|
1998-01-15 |
2004-03-09 |
Center For Molecular Medicine And Immunology |
Antibody/receptor targeting moiety for enhanced delivery of armed ligand
|
|
DE69916031T2
(de)
*
|
1998-01-29 |
2005-02-17 |
Poly-Med Inc. |
Asorbierbare mikropartikel
|
|
WO1999046392A1
(en)
|
1998-03-12 |
1999-09-16 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions of chemokine-tumor antigen fusion proteins as cancer vaccines
|
|
US6224794B1
(en)
|
1998-05-06 |
2001-05-01 |
Angiotech Pharmaceuticals, Inc. |
Methods for microsphere production
|
|
US7041287B2
(en)
|
1998-05-21 |
2006-05-09 |
Trustees Of The University Of Pennsylvania |
Compositions and methods for selective dissolution of nascent intravascular blood clots
|
|
WO1999059611A1
(en)
|
1998-05-21 |
1999-11-25 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots
|
|
AU4572899A
(en)
|
1998-06-16 |
2000-01-05 |
Biogen, Inc. |
Variant type ii tgf-beta receptor fusion proteins and methods
|
|
AU5090899A
(en)
|
1998-07-06 |
2000-01-24 |
University Of Tennessee Research Corporation, The |
Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
CA2345024C
(en)
|
1998-10-07 |
2009-05-19 |
Stryker Corporation |
Modified tgf-.beta. superfamily proteins
|
|
EP1046651A1
(en)
|
1999-04-19 |
2000-10-25 |
Koninklijke Universiteit Nijmegen |
Composition and method for modulating dendritic cell-T interaction
|
|
FR2794461B1
(fr)
*
|
1999-06-07 |
2004-01-23 |
Lab Francais Du Fractionnement |
Procede de preparation de nouvelles fractions d'ig humaines possedant une activite immunomodulatrice
|
|
AU7404800A
(en)
|
1999-09-30 |
2001-04-30 |
Novo Nordisk A/S |
A method for preparing conjugates between an antigen and mucosal binding component
|
|
GB9923306D0
(en)
|
1999-10-01 |
1999-12-08 |
Isis Innovation |
Diagnostic and therapeutic epitope, and transgenic plant
|
|
EP2213743A1
(en)
|
2000-04-12 |
2010-08-04 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CA2416656A1
(en)
|
2000-06-05 |
2002-04-04 |
University Of Tennessee Corporation |
Compositions and methods for the endocytic presentation of immunosuppressive factors
|
|
IL153853A0
(en)
|
2000-07-10 |
2003-07-31 |
Novartis Ag |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
WO2002011756A2
(en)
|
2000-08-07 |
2002-02-14 |
Entremed, Inc. |
Anti-plasmodium compositions and methods of use
|
|
GB0019302D0
(en)
|
2000-08-08 |
2000-09-27 |
Univ Nottingham Trent |
Biological materials and the use thereof for the treatment of disease
|
|
SE0003538D0
(sv)
|
2000-09-29 |
2000-09-29 |
Isconova Ab |
New immunogenic complex
|
|
WO2002055185A2
(en)
|
2000-10-19 |
2002-07-18 |
Eidgenoess Tech Hochschule |
Block copolymers for multifunctional self-assembled systems
|
|
US7470420B2
(en)
|
2000-12-05 |
2008-12-30 |
The Regents Of The University Of California |
Optical determination of glucose utilizing boronic acid adducts
|
|
US7175988B2
(en)
|
2001-02-09 |
2007-02-13 |
Human Genome Sciences, Inc. |
Human G-protein Chemokine Receptor (CCR5) HDGNR10
|
|
NZ527977A
(en)
|
2001-02-12 |
2005-10-28 |
Medarex Inc |
Human monoclonal antibodies to FC alpha receptor (CD89)
|
|
EP1241249A1
(en)
*
|
2001-03-12 |
2002-09-18 |
Gerold Schuler |
CD4+CD25+regulatory T cells from human blood
|
|
IL158171A0
(en)
|
2001-04-10 |
2004-03-28 |
Bioergonomics Inc |
Compositions and methods for cell separation
|
|
US7265208B2
(en)
*
|
2001-05-01 |
2007-09-04 |
The Regents Of The University Of California |
Fusion molecules and treatment of IgE-mediated allergic diseases
|
|
CA2446584A1
(en)
|
2001-05-09 |
2002-11-14 |
Ecd Systems, Inc. |
Systems and methods for the prevention of unauthorized use and manipulation of digital content
|
|
GB0113798D0
(en)
|
2001-06-06 |
2001-07-25 |
Chiron Spa |
Antigens and vectors for vaccination
|
|
EP1409009A1
(en)
|
2001-06-15 |
2004-04-21 |
Nordic Vaccine Technology A/S |
Therapeutical vaccination
|
|
IL160142A0
(en)
|
2001-08-17 |
2004-06-20 |
Anosys Inc |
Methods and compounds for the targeting of protein to exosomes
|
|
FR2829500B1
(fr)
|
2001-09-13 |
2003-12-12 |
Hemosystem |
Procede de concentration et de detection de germes pathogenes a partir de produits sanguins et/ou de leurs derives et dispositif pour le mettre en oeuvre
|
|
EP1443963B1
(en)
|
2001-10-22 |
2014-05-21 |
The Scripps Research Institute |
Antibody targeting compounds
|
|
CA2471532A1
(en)
|
2001-10-23 |
2003-05-01 |
Centre For Translational Research In Cancer |
A synthetic chimeric fusion protein with immuno-therapeutic uses
|
|
AU2002357072A1
(en)
|
2001-12-07 |
2003-06-23 |
Centocor, Inc. |
Pseudo-antibody constructs
|
|
GB0202399D0
(en)
|
2002-02-01 |
2002-03-20 |
Univ Bristol |
Peptide
|
|
WO2003066820A2
(en)
|
2002-02-05 |
2003-08-14 |
The Regents Of The University Of California |
Nucleic acid molecules encoding cd1-derived endosomal targeting proteins and uses thereof
|
|
GB0212885D0
(en)
|
2002-06-05 |
2002-07-17 |
Isis Innovation |
Therapeutic epitopes and uses thereof
|
|
DE60319103T2
(de)
*
|
2002-08-06 |
2009-02-05 |
Loma Linda University, Loma Linda |
Substanzen zur vorbeugung und behandlung von autoimmunkrankheiten
|
|
US20040146948A1
(en)
|
2002-10-18 |
2004-07-29 |
Centenary Institute Of Cancer Medicine And Cell Biology |
Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments
|
|
AU2003298650B2
(en)
*
|
2002-11-15 |
2010-03-11 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
|
US20060173168A1
(en)
|
2002-12-16 |
2006-08-03 |
Wayne State University |
Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20
|
|
NZ542134A
(en)
|
2003-03-04 |
2009-06-26 |
Alexion Pharma Inc |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
|
US20050281828A1
(en)
|
2003-03-04 |
2005-12-22 |
Bowdish Katherine S |
Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
|
|
WO2004096859A1
(ja)
|
2003-04-28 |
2004-11-11 |
Sekisui Chemical Co., Ltd. |
シャペロニン－目的タンパク質複合体及びその生産方法、目的タンパク質の安定化方法、目的タンパク質の固定化方法、目的タンパク質の構造解析方法、徐放性製剤、並びに目的タンパク質に対する抗体の製造方法
|
|
CA2524615A1
(en)
|
2003-05-12 |
2004-11-18 |
Tolerogen, Ltd. |
Immunoglobulin conjugates of autoantigens and their use in the prevention of disease
|
|
US8007805B2
(en)
|
2003-08-08 |
2011-08-30 |
Paladin Labs, Inc. |
Chimeric antigens for breaking host tolerance to foreign antigens
|
|
WO2005019429A2
(en)
|
2003-08-22 |
2005-03-03 |
Potentia Pharmaceuticals, Inc. |
Compositions and methods for enhancing phagocytosis or phagocyte activity
|
|
US20050100964A1
(en)
*
|
2003-11-11 |
2005-05-12 |
George Jackowski |
Diagnostic methods for congestive heart failure
|
|
WO2005051174A2
(en)
|
2003-11-21 |
2005-06-09 |
The Trustees Of Columbia University In The City Of New York |
Nucleic acid aptamer-based compositions and methods
|
|
US20110064754A1
(en)
|
2005-03-03 |
2011-03-17 |
Center For Molecular Medicine And Immunology |
Immunoconjugates Comprising Poxvirus-Derived Peptides and Antibodies Against Antigen-Presenting Cells for Subunit-Based Poxvirus Vaccines
|
|
FR2869323B1
(fr)
*
|
2004-04-22 |
2006-07-21 |
Univ Reims Champagne Ardenne |
Utilisation du gene codant la chaine beta de la proteine c4bp dans la production de proteines dimeriques recombinantes
|
|
AU2005237287B2
(en)
|
2004-04-28 |
2011-08-11 |
Btg International Limited |
Epitopes related to coeliac disease
|
|
EP1771733A2
(en)
|
2004-06-24 |
2007-04-11 |
The Scripps Research Institute |
Arrays with cleavable linkers
|
|
US8273357B2
(en)
|
2004-07-16 |
2012-09-25 |
Massachusetts Institute Of Technology |
Antigen-carbohydrate conjugates
|
|
CA2574802A1
(en)
*
|
2004-07-20 |
2006-02-02 |
Isogenis, Inc. |
Specific inhibition of autoimmunity and diseases associated with autoantigens
|
|
FR2873925B1
(fr)
|
2004-08-05 |
2006-10-13 |
Erytech Pharma Soc Par Actions |
Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
US8617819B2
(en)
|
2004-09-17 |
2013-12-31 |
Massachusetts Institute Of Technology |
Polymers for analyte detection
|
|
US20080233143A1
(en)
|
2005-02-07 |
2008-09-25 |
Lipotek Pty Ltd. |
Adjuvanting Material
|
|
ES2665422T3
(es)
|
2005-03-03 |
2018-04-25 |
Immunomedics Inc. |
Anticuerpos L243 humanizados
|
|
FR2884717B1
(fr)
|
2005-04-25 |
2009-07-03 |
Erytech Pharma Soc Par Actions |
Erythrocytes renfermant de l'arginine deiminase
|
|
WO2007008300A2
(en)
|
2005-05-31 |
2007-01-18 |
ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE |
Triblock copolymers for cytoplasmic delivery of gene-based drugs
|
|
US7811809B2
(en)
|
2005-06-15 |
2010-10-12 |
Saint Louis University |
Molecular biosensors for use in competition assays
|
|
HRP20131066T1
(hr)
|
2005-07-08 |
2013-12-06 |
Biogen Idec Ma Inc. |
Sp35 antitijela i njihova upotreba
|
|
FI20050814A0
(fi)
|
2005-08-11 |
2005-08-11 |
Procollagen Oy |
Menetelmä nivelreumassa muodostuvien kollageeniautovasta-aineiden havaitsemiseksi
|
|
US20090130104A1
(en)
|
2005-10-05 |
2009-05-21 |
The Trustees Of The University Of Pennsylvania |
Fusion proteins for inhibition and dissolution of coagulation
|
|
US8440191B2
(en)
|
2005-11-18 |
2013-05-14 |
Tufts Medical Center |
Clearance of abnormal IGA1 in IGA1 deposition diseases
|
|
WO2007097934A2
(en)
*
|
2006-02-17 |
2007-08-30 |
Elusys Therapeutics, Inc. |
Methods and compositions for using erythrocytes as carriers for delivery of drugs
|
|
US8021689B2
(en)
|
2006-02-21 |
2011-09-20 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
Nanoparticles for immunotherapy
|
|
US20080213267A1
(en)
|
2006-02-24 |
2008-09-04 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US20080305104A1
(en)
|
2006-02-24 |
2008-12-11 |
Young David S F |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US7420040B2
(en)
|
2006-02-24 |
2008-09-02 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
US20080131428A1
(en)
|
2006-02-24 |
2008-06-05 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
WO2007099387A1
(en)
|
2006-03-03 |
2007-09-07 |
Mymetics Corporation |
Virosome-like vesicles comprising gp41-derived antigens
|
|
ZA200808289B
(en)
*
|
2006-03-09 |
2010-02-24 |
Aplagen Gmbh |
Modified molecules which promote hematopoiesis
|
|
US20090238883A1
(en)
|
2006-04-28 |
2009-09-24 |
Kren Betsy T |
Liver-specific nanocapsules and methods of using
|
|
CA2690973A1
(en)
|
2006-06-23 |
2007-12-27 |
Paul M. Simon |
Targeted immune conjugates
|
|
AU2007306936B2
(en)
|
2006-10-12 |
2014-02-06 |
The University Of Queensland |
Compositions and methods for modulating immune responses
|
|
EP2091568A2
(en)
|
2006-10-31 |
2009-08-26 |
East Carolina University |
Fusion proteins comprising a anti-inflammatory cytokine and an antigen for treatment of immune disorders
|
|
JP2010509235A
(ja)
|
2006-11-03 |
2010-03-25 |
ノースウェスタン ユニバーシティ |
多発性硬化症の治療
|
|
ES2397186T3
(es)
|
2006-11-06 |
2013-03-05 |
Whitehead Institute |
Composiciones inmunomoduladoras y métodos para su uso
|
|
US9457047B2
(en)
|
2006-11-06 |
2016-10-04 |
Whitehead Institute |
Immunomodulating compositions and methods of use thereof
|
|
EP1938836A1
(en)
|
2006-12-28 |
2008-07-02 |
Universite Rene Descartes (Paris V) |
Compositions comprising a B subunit of shiga toxin and a means stimulating NKT cells
|
|
TWI422594B
(zh)
|
2007-02-02 |
2014-01-11 |
Baylor Res Inst |
經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑
|
|
CN101657464A
(zh)
|
2007-02-02 |
2010-02-24 |
贝勒研究院 |
与靶向人源化单克隆抗体复合的多变量抗原
|
|
KR20090114430A
(ko)
|
2007-02-02 |
2009-11-03 |
베일러 리서치 인스티튜트 |
항원-제시 세포 상에서 발현된 ｄｃｉｒ에 대한 항원 표적화에 기초한 백신
|
|
TW200846363A
(en)
|
2007-03-22 |
2008-12-01 |
Urrma R & B |
Novel human anti-R7V antibodies and uses thereof
|
|
CN101743249B
(zh)
|
2007-05-11 |
2017-08-08 |
阿尔托生物科学有限公司 |
融合分子与il‑15变异体
|
|
US8889140B2
(en)
|
2007-05-31 |
2014-11-18 |
Transtarget, Inc. |
Compositions and methods for tissue repair
|
|
US7507539B2
(en)
|
2007-07-30 |
2009-03-24 |
Quest Diagnostics Investments Incorporated |
Substractive single label comparative hybridization
|
|
RU2010107199A
(ru)
|
2007-07-31 |
2011-09-10 |
Дзе Джонс Хопкинс Юниверсити (Us) |
Конъюгат полипептид-нуклеиновая кислота для иммунопрофилактики или иммунотерапии для неопластических или инфекционных нарушений
|
|
FR2919804B1
(fr)
|
2007-08-08 |
2010-08-27 |
Erytech Pharma |
Composition et vaccin therapeutique anti-tumoral
|
|
CA2696699A1
(en)
|
2007-08-20 |
2009-02-26 |
Protalix Ltd. |
Saccharide-containing protein conjugates and uses thereof
|
|
JP2011500569A
(ja)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
|
US9260692B2
(en)
|
2007-10-31 |
2016-02-16 |
Universitat Zurich |
Use of modified cells for the treatment of multiple sclerosis
|
|
EP2057998A1
(en)
|
2007-10-31 |
2009-05-13 |
Universitätsklinikum Hamburg-Eppendorf |
Use of modified cells for the treatment of multiple sclerosis
|
|
CA2708942A1
(en)
*
|
2007-12-19 |
2009-06-25 |
Mivac Development Aktiebolag |
Compositions and methods for treatment of autoimmune and allergic diseases
|
|
FR2925339B1
(fr)
|
2007-12-24 |
2010-03-05 |
Erytech Pharma |
Medicament pour le traitement du cancer du pancreas
|
|
WO2009086552A1
(en)
|
2008-01-02 |
2009-07-09 |
The Trustees Of The University Of Pennsylvania |
Targeting recombinant therapeutics to circulating red blood cells
|
|
WO2009101467A1
(en)
|
2008-02-13 |
2009-08-20 |
Erytech Pharma |
Formulation and method for the prevention and treatment of skeletal manifestation of gaucher's disease
|
|
FR2928270B1
(fr)
|
2008-03-10 |
2011-01-21 |
Erytech Pharma |
Formulation methode pour la prevention ou le traitement des metastases osseuses et autres maladies de l'os
|
|
EP2268673B1
(en)
|
2008-03-28 |
2017-10-25 |
The Regents of The University of California |
Polypeptide-polymer conjugates and methods of use thereof
|
|
CA2719718C
(en)
|
2008-03-28 |
2019-07-02 |
Mdna Life Sciences Inc. |
Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
|
|
JP2011519049A
(ja)
|
2008-04-29 |
2011-06-30 |
イミューンエクサイト インコーポレイテッド |
免疫調節組成物およびその使用方法
|
|
US8852640B2
(en)
|
2008-07-03 |
2014-10-07 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Micelles for delivery of nitric oxide
|
|
CA2729961C
(en)
|
2008-07-09 |
2018-05-01 |
Biogen Idec Ma Inc. |
Li113, li62 variant co2, anti-lingo antibodies
|
|
US8323696B2
(en)
|
2008-08-29 |
2012-12-04 |
Ecole Polytechnique Federale De Lausanne |
Nanoparticles for immunotherapy
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
CN101750244B
(zh)
*
|
2008-10-13 |
2014-03-12 |
艾博生物医药(杭州)有限公司 |
一种分离血液样本中红细胞的方法以及运用
|
|
WO2010045518A1
(en)
|
2008-10-16 |
2010-04-22 |
The Trustees Of The University Of Pennsylvania |
Compositions containing thrombomodulin domains and uses thereof
|
|
FR2938332B1
(fr)
|
2008-11-07 |
2011-11-25 |
Erytech Pharma |
Test predictif de la neutralisation de l'activite asparaginase
|
|
US8268977B2
(en)
|
2008-11-20 |
2012-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Strongly quenching oligomeric excimer/quencher pairs for detection schemes
|
|
HUE027237T2
(en)
|
2008-11-30 |
2016-10-28 |
Immusant Inc |
Compositions and methods for treatment of celiac disease
|
|
FR2940087B1
(fr)
|
2008-12-18 |
2011-05-06 |
Lab Francais Du Fractionnement |
Erythrocytes contenant du facteur viii, preparation et utilisations.
|
|
TW201039843A
(en)
|
2009-01-20 |
2010-11-16 |
Myelin Repair Foundation Inc |
Compositions and methods for induced tolerance
|
|
AU2010222942B2
(en)
|
2009-03-10 |
2013-01-10 |
Baylor Research Institute |
Anti-CD40 antibodies and uses thereof
|
|
DK2406289T3
(en)
|
2009-03-10 |
2017-05-01 |
Baylor Res Inst |
ANTIGEN PRESENTING CELL TARGETED ANTIVIRUS VACCINES
|
|
CN102770457A
(zh)
|
2009-03-10 |
2012-11-07 |
贝勒研究院 |
靶向抗原呈递细胞的疫苗
|
|
WO2010107658A2
(en)
|
2009-03-16 |
2010-09-23 |
Vallera Daniel A |
Methods and compositions for bi-specific targeting of cd19/cd22
|
|
FR2944106B1
(fr)
|
2009-04-03 |
2012-09-28 |
Erytech Pharma |
Methode de dosage de l'inositol hexaphosphate (ihp).
|
|
CA2769162C
(en)
|
2009-07-31 |
2017-12-05 |
Ascendis Pharma As |
Biodegradable polyethylene glycol based water-insoluble hydrogels
|
|
CA2772204A1
(en)
|
2009-08-31 |
2011-03-03 |
Amplimmune, Inc. |
Methods and compositions for the inhibition of transplant rejection
|
|
US8734786B2
(en)
|
2009-09-16 |
2014-05-27 |
Northwestern University |
Use of ECDI-fixed cell tolerance as a method for preventing allograft rejection
|
|
GB0916749D0
(en)
|
2009-09-23 |
2009-11-04 |
Mologic Ltd |
Peptide cleaning agents
|
|
US20110091493A1
(en)
|
2009-10-16 |
2011-04-21 |
Northwestern University |
Vaccine compositions and uses thereof
|
|
AU2010311515B2
(en)
|
2009-10-27 |
2014-02-20 |
Erytech Pharma |
Composition to induce specific immune tolerance
|
|
WO2011072290A2
(en)
|
2009-12-11 |
2011-06-16 |
The Regents Of The University Of Michigan |
Targeted dendrimer-drug conjugates
|
|
WO2011086143A2
(en)
|
2010-01-14 |
2011-07-21 |
Glaxo Group Limited |
Liver targeting molecules
|
|
US9096655B2
(en)
|
2010-01-27 |
2015-08-04 |
Tata Memorial Centre |
Method for in-vivo binding of chromatin fragments
|
|
EP2547328B1
(en)
|
2010-02-11 |
2017-06-07 |
Ecole Polytechnique Fédérale de Lausanne (EPFL) |
Ccr7 ligand delivery and co-delivery in immunotherapy
|
|
WO2011112482A2
(en)
|
2010-03-08 |
2011-09-15 |
University Of Utah Research Foundation |
Polymeric drug delivery conjugates and methods of making and using thereof
|
|
IT1399590B1
(it)
|
2010-04-26 |
2013-04-26 |
Erydel Spa |
Apparato e kit per incapsulare almeno un composto ad uso terapeutico e/o diagnostico all'interno di eritrociti
|
|
EP2563753B9
(en)
|
2010-04-27 |
2016-07-06 |
SynAffix B.V. |
Fused cyclooctyne compounds and their use in metal-free click reactions
|
|
EP2563396A2
(en)
|
2010-04-30 |
2013-03-06 |
Augmenta Biologicals LLC |
Delivery proteins
|
|
US9522183B2
(en)
|
2010-07-31 |
2016-12-20 |
The Scripps Research Institute |
Compositions and methods for inducing immune tolerance
|
|
EP2618817B1
(en)
|
2010-07-31 |
2018-06-13 |
The Scripps Research Institute |
Liposome targeting compounds and related uses
|
|
WO2013121296A1
(en)
|
2012-02-15 |
2013-08-22 |
Ecole Polytechnique Federale De Lausanne |
Erythrocyte-binding therapeutics
|
|
US9517257B2
(en)
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
US9850296B2
(en)
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
|
EP2603520A4
(en)
|
2010-08-10 |
2014-02-19 |
Ecole Polytech |
ERYTHROCYTE BINDING THERAPEUTICS
|
|
US9175280B2
(en)
|
2010-10-12 |
2015-11-03 |
Sangamo Biosciences, Inc. |
Methods and compositions for treating hemophilia B
|
|
US20120121592A1
(en)
|
2010-10-13 |
2012-05-17 |
Baylor Research Institute |
Targeting Antigens to Human Dendritic Cells Via DC-Asialoglycoprotein Receptor to Produce IL-10 Regulatory T-Cells
|
|
SE535625C2
(sv)
|
2010-10-28 |
2012-10-16 |
Toleranzia Ab |
Nya kompositioner och förfaranden för behandling av autoimmuna och allergiska sjukdomar
|
|
US8501930B2
(en)
|
2010-12-17 |
2013-08-06 |
Arrowhead Madison Inc. |
Peptide-based in vivo siRNA delivery system
|
|
WO2012112690A2
(en)
|
2011-02-16 |
2012-08-23 |
Fabius Biotechnology |
Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains
|
|
JP6460789B2
(ja)
|
2011-06-03 |
2019-01-30 |
スリーエム イノベイティブ プロパティズ カンパニー |
ポリエチレングリコールセグメントを有するヘテロ２官能性リンカー及び該リンカーから調製された免疫反応調節複合体
|
|
EP2811831B1
(en)
|
2012-02-07 |
2018-04-11 |
The Regents Of The University Of California |
Glycosphingolipids for use in modulating immune responses
|
|
US9751945B2
(en)
|
2012-04-13 |
2017-09-05 |
Whitehead Institute For Biomedical Research |
Sortase-modified VHH domains and uses thereof
|
|
WO2013160865A1
(en)
|
2012-04-26 |
2013-10-31 |
Toleranzia Ab |
Immunotolerizing fusion proteins for treatment of multiple sclerosis
|
|
WO2014011465A2
(en)
|
2012-07-13 |
2014-01-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Aptamer-targeted antigen delivery
|
|
CA2878626A1
(en)
|
2012-08-09 |
2014-02-13 |
Roche Glycart Ag |
Asgpr antibodies and uses thereof
|
|
US10548957B2
(en)
|
2012-09-28 |
2020-02-04 |
Dana-Farber Cancer Institute, Inc. |
Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis
|
|
US9371352B2
(en)
|
2013-02-08 |
2016-06-21 |
Vaccinex, Inc. |
Modified glycolipids and methods of making and using the same
|
|
WO2014135528A1
(en)
|
2013-03-04 |
2014-09-12 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Fusion proteins and immunoconjugates and uses thereof
|
|
EP2983791A4
(en)
|
2013-04-11 |
2016-11-09 |
Brigham & Womens Hospital |
METHOD AND COMPOSITIONS FOR TREATING AUTOIMMUNE DISEASES
|
|
CA2910110A1
(en)
|
2013-04-22 |
2014-10-30 |
The Scripps Research Institute |
Methods and compositions for treating bleeding disorders
|
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
SG11201606761RA
(en)
|
2014-02-21 |
2016-09-29 |
Ecole Polytecnique Federale De Lausanne Epfl Epfl Tto |
Glycotargeting therapeutics
|
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
|
MA39819A
(fr)
|
2014-04-01 |
2017-02-08 |
Rubius Therapeutics Inc |
Méthodes et compositions d'immunomodulation
|
|
JP6685924B2
(ja)
|
2014-04-11 |
2020-04-22 |
メディミューン，エルエルシー |
システイン操作抗体を含むコンジュゲート化合物
|
|
CA2948165A1
(en)
|
2014-05-08 |
2015-11-12 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Using b-cell-targeting antigen igg fusion as tolerogenic protein therapy for treating adverse immune responses
|
|
WO2015175957A1
(en)
|
2014-05-16 |
2015-11-19 |
Baylor Research Institute |
Methods and compositions for treating autoimmune and inflammatory conditions
|
|
WO2016022971A1
(en)
|
2014-08-08 |
2016-02-11 |
The Board Of Trustees Of The Leland Stanford Junior University |
Sirp alpha-antibody fusion proteins
|
|
US20160060358A1
(en)
|
2014-08-28 |
2016-03-03 |
California Institute Of Technology |
Induction of antigen-specific tolerance
|
|
IL315468A
(en)
|
2014-09-17 |
2024-11-01 |
Spogen Biotech Inc |
Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria
|
|
MA40861A
(fr)
|
2014-10-31 |
2017-09-05 |
Biogen Ma Inc |
Anticorps anti-glycoprotéines iib/iiia
|
|
WO2016161372A1
(en)
|
2015-04-01 |
2016-10-06 |
President And Fellows Of Harvard College |
Immunoconjugates for programming or reprogramming of cells
|
|
US20180104284A1
(en)
|
2015-05-13 |
2018-04-19 |
Advaxis, Inc. |
Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use Thereof
|
|
CN107709356A
(zh)
|
2015-06-26 |
2018-02-16 |
南加利福尼亚大学 |
用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞
|
|
WO2017015141A1
(en)
|
2015-07-17 |
2017-01-26 |
President And Fellows Of Harvard College |
Humanized anti-glycophorin a antibodies and uses thereof
|
|
CA2993429A1
(en)
|
2015-07-31 |
2017-02-09 |
Tarveda Therapeutics, Inc. |
Compositions and methods for immuno-oncology therapies
|
|
WO2017025889A1
(en)
|
2015-08-13 |
2017-02-16 |
Pfizer Inc. |
Polymeric nanoparticles with dec-205 ligand and co-encapsulating an antigen subject to an autoimmune response and a glucocorticoid receptor agonist
|
|
US10864170B2
(en)
|
2015-09-04 |
2020-12-15 |
Yale University |
Polymeric bile acid nanocompositions targeting the pancreas and colon
|
|
US10294294B2
(en)
|
2015-09-10 |
2019-05-21 |
Albert Einstein College Of Medicine |
Synthetic antibodies to BAX and uses thereof
|
|
KR20180080195A
(ko)
|
2015-09-19 |
2018-07-11 |
에꼴 뽈리떼끄닉 뻬데랄 드 로잔느 (으뻬에프엘) |
글리코타겟팅 치료제
|
|
EP3356371A4
(en)
|
2015-09-29 |
2020-06-24 |
The University of Chicago |
POLYMER CONJUGATE VACCINE
|
|
US10688175B2
(en)
|
2015-10-13 |
2020-06-23 |
Daniel C. Carter |
NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications
|
|
EP3701963A1
(en)
|
2015-12-22 |
2020-09-02 |
CureVac AG |
Method for producing rna molecule compositions
|
|
JP7194593B2
(ja)
|
2015-12-23 |
2022-12-22 |
クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド |
共有ポリマー抗原コンジュゲート化粒子
|
|
WO2017139498A1
(en)
|
2016-02-09 |
2017-08-17 |
Cour Pharmaceuticals Development Company Inc. |
Timps encapsulating japanese cedar pollen epitopes
|
|
US20190046620A1
(en)
|
2016-02-12 |
2019-02-14 |
Bloodworks |
Therapeutic induction of tolerance using recombinant cell surface antigens
|
|
WO2017155981A1
(en)
|
2016-03-07 |
2017-09-14 |
Massachusetts Institute Of Technology |
Protein-chaperoned t-cell vaccines
|
|
AU2017259988B2
(en)
|
2016-05-03 |
2023-04-27 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to induce tolerance
|
|
CA3023092A1
(en)
|
2016-05-03 |
2017-11-09 |
Sqz Biotechnologies Company |
Intracellular delivery of biomolecules to induce tolerance
|
|
US20170326213A1
(en)
|
2016-05-16 |
2017-11-16 |
Augusta University Research Institute, Inc. |
Protein-Coupled Red Blood Cell Compositions and Methods of Their Use
|
|
JP6687498B2
(ja)
|
2016-10-25 |
2020-04-22 |
住友ナコ フォ−クリフト株式会社 |
カメラ用装着ブラケット
|
|
WO2018232176A1
(en)
|
2017-06-16 |
2018-12-20 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
|
KR102774451B1
(ko)
|
2017-11-14 |
2025-02-28 |
앱클론(주) |
항-her2 항체 또는 그의 항원 결합 단편, 및 이를 포함하는 키메라 항원 수용체
|
|
US20210171642A1
(en)
|
2018-03-26 |
2021-06-10 |
The University Of Chicago |
Methods and compositions for targeting liver and lymph node sinusoidal endothelial cell c-type lectin (lsectin)
|
|
JP2021522812A
(ja)
|
2018-05-07 |
2021-09-02 |
アノキオン・ソシエテ・アノニムＡｎｏｋｉｏｎ Ｓａ |
グリコフォリンａ抗原結合タンパク質
|
|
CN113710229B
(zh)
*
|
2019-02-25 |
2026-01-06 |
芝加哥大学 |
用与抗炎剂连接的ecm亲和肽治疗炎症性和自身免疫性病症的方法和组合物
|